LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-u...

FDA Recall #D-0140-2024 — Class III — November 9, 2023

Recall #D-0140-2024 Date: November 9, 2023 Classification: Class III Status: Terminated

Product Description

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1

Reason for Recall

Product Mix-up: Incorrect Product Formulation

Recalling Firm

Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop — Irving, TX

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

190 syringes

Distribution

USA Nationwide

Code Information

Lot#: 09202023@7, Exp 03/18/2024

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated